Business Review 2026

← 2025 2027 →

Demo CRO Add your job title and start date

As of 2026-09-16 · Q3 · Jul-Sep

A management review of what was planned, what completed, what matters now, and where attention is needed.

How this review works

Every figure is calculated from Deals, Forecast, and current evidence when the page loads.
Won uses the period a deal closed. Evidence uses approved quotes on open deals. Your call uses open deals marked In call.
Closed deals leave the call and Evidence totals, so nothing is counted twice.
To change a number, follow its link to the screen that owns it.

Business Summary

Quota

$3,937,500 Q1

Won

$48,137 1 completed

Forecast call

$3,014,000 1 in call

Quote Evidence

$0 Approved quotes

What Matters Now

What to talk about 3 points

Your call for Q1 2026 is $3,014,000; $923,500 under the quota.Either the quota needs more pipeline behind it, or the call needs the deals you haven't ticked.
1 of the 1 deal you've ticked into your call has no evidence value at all; $21,235,101 of what you're calling.These are the ones to talk through: they are being carried on your word.
$48,137 won against the $3,937,500 quota; 1%, $3,889,363 still to find.

Forecast Commitments

1 in call

The deals this rep has committed to the forecast for this timeframe.

Deal	Expected close	Stage	Amount	Call	Quote Evidence	Attention
Northstar Labs Expansion at Northstar Labs	2026-03-15	Business Qualification	$21,235,101	In call	$0	Call has no Quote Evidence 15 evidence requirements incomplete

All Deals Being Worked

1 open

Every open deal expected to close in this timeframe, including deals outside the forecast call.

Deal	Expected close	Stage	Amount	Call	Quote Evidence	Attention
Northstar Labs Expansion at Northstar Labs	2026-03-15	Business Qualification	$21,235,101	In call	$0	Call has no Quote Evidence 15 evidence requirements incomplete

Deal and Evidence Completeness

0 of 1 deal records are complete for management review.

Northstar Labs Expansion at Northstar LabsNeeds attention

1 of 16 evidence requirements complete · In call · Close 2026-03-15

15 missing evidence requirements

Metric agreed · Economic buyer engaged · Decision process documented · Champion validated · Use cases documented · Demo delivered · Use cases confirmed · Evaluation kicked off · Evaluation passed · RFI / RFP submitted · Security questionnaire returned · Paper process documented · Quote approved · Redlines resolved · Signatory confirmed

Gaps Requiring Discussion

1 need attention

Northstar Labs Expansion at Northstar LabsCall has no Quote Evidence · 15 evidence requirements incomplete$21,235,101

Completed Business

1 won · 0 lost

Deal	Completed	Outcome	Amount	What happened
Harbor Health Completed outcome at Harbor Health	2026-01-12	Won	$48,137	The analytics team validated the required reporting workflow and selected the platform. Demo CRO's final agreement was recorded for the public demonstration.

Leadership Discussion

Use the gaps above to agree on the support needed. This review does not invent help requests that the rep has not recorded.

Decisions
Executive access
Technical help
Commercial help
Deal strategy

Business review; Q1 2026 (as of 2026-09-16)
Demo CRO

Quota      $3,937,500
Won        $48,137 (1% of quota); 1 deal
Your call  $3,014,000
Evidence   $0


Open pipeline: 1 deal; your call $21,235,101, evidence $0, unproven $21,235,101, 1 unproven deal
Closed: 1 deal; 1 won ($48,137), 0 lost ($0), win rate 100% over 1 settled deal
Leads (current list, not filtered by quarter): 0 on the list; 0% worked, 0 became deals (0%), 0 gone cold

To talk about:
- Your call for Q1 2026 is $3,014,000; $923,500 under the quota.
- 1 of the 1 deal you've ticked into your call has no evidence value at all; $21,235,101 of what you're calling.
- $48,137 won against the $3,937,500 quota; 1%, $3,889,363 still to find.